Triple

T23417454
Position Surface form Disambiguated ID Type / Status
Subject Bristol Myers Squibb E560549 entity
Predicate product P490 FINISHED
Object Eliquis NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Eliquis | Statement: [Bristol Myers Squibb, product, Eliquis]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Eliquis
Context triple: [Bristol Myers Squibb, product, Eliquis]
  • A. Xarelto
    Xarelto is a widely used prescription anticoagulant (blood thinner) that helps prevent and treat blood clots and reduce the risk of stroke in certain patients.
  • B. Brilinta
    Brilinta is a prescription antiplatelet medication (ticagrelor) used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome or a history of myocardial infarction.
  • C. Plavix
    Plavix is a widely used prescription antiplatelet medication (clopidogrel) that helps prevent blood clots and reduce the risk of heart attack and stroke.
  • D. apixaban chosen
    Apixaban is an oral anticoagulant (factor Xa inhibitor) used to prevent and treat blood clots and reduce the risk of stroke in patients with conditions such as atrial fibrillation.
  • E. dabigatran
    Dabigatran is an oral direct thrombin inhibitor anticoagulant used to prevent and treat blood clots and reduce the risk of stroke in patients with conditions like atrial fibrillation.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454cb1108190ab21ada5411a7146 completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1a516d158819081e9710b4e372a21 completed April 29, 2026, 6:28 a.m.
Created at: April 17, 2026, 5:39 p.m.